SCHEMBL9201655

SCHEMBL9201655

OC(c1ccccc1)(c1ccccc1)[C@@H]1OC(c2ccccc2)(c2ccccc2)O[C@H]1C(O)(c1ccccc1)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.63
CYP3A4 P08684 1/20 0.63
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
CYP2D6 P10635 2/20 0.39
LMNA P02545 2/20 0.39
HRH1 P35367 1/20 0.39
SCN1A P35498 1/20 0.39
SCN2A Q99250 1/20 0.39
SCN3A Q9NY46 1/20 0.39
CYP2C19 P33261 3/20 0.36
CYP1A2 P05177 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
CHRM3 P20309 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
ATM Q13315 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8007551 1.00 MAPK1 (0.63) MAPK1CYP3A4MEN1KMT2ACYP2D6
SCHEMBL8007579 0.81 MAPK1 (0.70) MAPK1CYP3A4MEN1KMT2ACYP2D6
SCHEMBL8538968 0.81 MAPK1 (0.70) MAPK1CYP3A4MEN1KMT2ACYP2D6
SCHEMBL8538845 0.81 MAPK1 (0.70) MAPK1CYP3A4MEN1KMT2ACYP2D6
SCHEMBL8146997 0.79 MAPK1 (0.58) MAPK1CYP3A4MEN1KMT2ACYP2D6
SCHEMBL7916942 0.78 MAPK1 (1.00) MAPK1CYP3A4MEN1KMT2ACYP2D6
SCHEMBL7994941 0.78 MAPK1 (1.00) MAPK1CYP3A4MEN1KMT2ACYP2D6
SCHEMBL2534650 0.78 MAPK1 (1.00) MAPK1CYP3A4MEN1KMT2ACYP2D6
SCHEMBL2504692 0.78 MAPK1 (1.00) MAPK1CYP3A4MEN1KMT2ACYP2D6
SCHEMBL4383952 0.78 MAPK1 (1.00) MAPK1CYP3A4MEN1KMT2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11168097-B2 Photochemical methods of making cyclobutane boronates and related compounds WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2021-11-09 US disclosed
US-20200223870-A1 PHOTOCHEMICAL METHODS OF MAKING CYCLOBUTANE BORONATES AND RELATED COMPOUNDS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2020-07-16 US disclosed
US-10618917-B2 Photochemical methods of making cyclobutane boronates and related compounds WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2020-04-14 US disclosed
US-20190040085-A1 PHOTOCHEMICAL METHODS OF MAKING CYCLOBUTANE BORONATES AND RELATED COMPOUNDS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2019-02-07 US disclosed
EP-0387196-B1 Complexes with optically active ligands, process for their preparation and their use CIBA GEIGY AG (CH) 1995-05-03 EP disclosed
US-5047557-A Complexes having optically active ligands, a process for their preparation and their use CIBA-GEIGY CORPORATION (US) 1991-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11168097-B2 Photochemical methods of making cyclobutane boronates and related compounds BLVRB, CYP11B2, CYP11B1 MAPK1 1889/4885CYP3A4 78/4885MEN1 643/4885
US-20190040085-A1 PHOTOCHEMICAL METHODS OF MAKING CYCLOBUTANE BORONATES AND RELATED COMPOUNDS BLVRB, CYP11B1, CYP11B2 MAPK1 1887/4885CYP3A4 78/4885MEN1 619/4885
US-10618917-B2 Photochemical methods of making cyclobutane boronates and related compounds BLVRB, CYP11B2, CYP11B1 MAPK1 1889/4885CYP3A4 78/4885MEN1 643/4885
US-20200223870-A1 PHOTOCHEMICAL METHODS OF MAKING CYCLOBUTANE BORONATES AND RELATED COMPOUNDS BLVRB, CYP11B2, CYP11B1 MAPK1 1889/4885CYP3A4 78/4885MEN1 643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.